EmsanaRx integrates with existing employer-sponsored drug benefits so beneficiaries can find discounts and lower-cost medications without going outside their health insurance. Mr. Cuban’s online drug company has nearly 1,000 generic drugs at steep discounts.
EmsanaRx Plus is “a first-of-its-kind supplemental drug discount product designed specifically for employers,” the two companies said in a news release.
“Employers are increasingly recognizing that they’re being held hostage by a consolidated industry playing games that cost them more every year without adding value,” Greg Baker, CEO of EmsanaRx, said in a statement. “In partnering with Cost Plus Drugs, we will help employers understand where high-cost drugs are a problem in their current benefit design and give them and their employees access to lower-cost alternatives.”
This is the second pharmacy benefit manager Cost Plus Drugs has partnered with; in late September, it teamed up with Rightway after deciding to not make its own PBM.
Other recent moves from Mr. Cuban’s drug company includes a potential entrance into the insulin market. On Dec. 7, the company’s Twitter account said it was “evaluating a future insulin test program” and seeking consumer feedback.
“If we offered a 90-day supply of a fast-acting insulin (up to 12 vials/8 packs of pens) for $170 incl. shipping, what would you think?” the account tweeted.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
